Literature DB >> 16626888

Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion.

Adam C Riegel1, Anthony M Berson, Sylvie Destian, Tracy Ng, Lawrence B Tena, Robin J Mitnick, Ping S Wong.   

Abstract

PURPOSE: To assess the need for gross tumor volume (GTV) delineation protocols in head-and-neck cancer (HNC) treatment planning by use of positron emission tomography (PET)/computed tomography (CT) fusion imaging. Assessment will consist of interobserver and intermodality variation analysis. METHODS AND MATERIALS: Sixteen HNC patients were accrued for the study. Four physicians (2 neuroradiologists and 2 radiation oncologists) contoured GTV on 16 patients. Physicians were asked to contour GTV on the basis of the CT alone, and then on PET/CT fusion. Statistical analysis included analysis of variance for interobserver variability and Student's paired sample t test for intermodality and interdisciplinary variability. A Boolean pairwise analysis was included to measure degree of overlap.
RESULTS: Near-significant variation occurred across physicians' CT volumes (p = 0.09) and significant variation occurred across physicians' PET/CT volumes (p = 0.0002). The Boolean comparison correlates with statistical findings. One radiation oncologist's PET/CT fusion volumes were significantly larger than his CT volumes (p < 0.01). Conversely, the other radiation oncologist's CT volumes tended to be larger than his fusion volumes (p = 0.06). No significant interdisciplinary variation was seen. Significant disagreement occurred between radiation oncologists.
CONCLUSION: Significant differences in GTV delineation were found between multiple observers contouring on PET/CT fusion. The need for delineation protocol has been confirmed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16626888     DOI: 10.1016/j.ijrobp.2006.01.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  55 in total

1.  Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy.

Authors:  Tony Shepherd; Mika Teras; Reinhard R Beichel; Ronald Boellaard; Michel Bruynooghe; Volker Dicken; Mark J Gooding; Peter J Julyan; John A Lee; Sébastien Lefèvre; Michael Mix; Valery Naranjo; Xiaodong Wu; Habib Zaidi; Ziming Zeng; Heikki Minn
Journal:  IEEE Trans Med Imaging       Date:  2012-06-04       Impact factor: 10.048

Review 2.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques.

Authors:  Habib Zaidi; Issam El Naqa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-25       Impact factor: 9.236

3.  Overcoming the hurdles of using PET/CT for target volume delineation in curative intent radiotherapy of non-small cell lung cancer.

Authors:  Leila Tchelebi; Hani Ashamalla
Journal:  Ann Transl Med       Date:  2015-08

Review 4.  Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.

Authors:  P M Price; M M Green
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

5.  PET/CT in head and neck cancer.

Authors:  Liselotte Højgaard; Lena Specht
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09       Impact factor: 9.236

6.  A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours.

Authors:  Hua Li; Wade L Thorstad; Kenneth J Biehl; Richard Laforest; Yi Su; Kooresh I Shoghi; Eric D Donnelly; Daniel A Low; Wei Lu
Journal:  Med Phys       Date:  2008-08       Impact factor: 4.071

7.  FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.

Authors:  Voichita Bar-Ad; Wenyin Shi; Madalina Tuluc; Nitin Ohri; David Cognetti; Joseph Curry; Charles Intenso
Journal:  J Nucl Med Radiat Ther       Date:  2012-02-01

Review 8.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

9.  Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma.

Authors:  Adam A Garsa; Albert J Chang; Todd Dewees; Christopher R Spencer; Douglas R Adkins; Farrokh Dehdashti; Hiram A Gay; Wade L Thorstad
Journal:  J Radiat Oncol       Date:  2013-03

Review 10.  PET imaging biomarkers in head and neck cancer.

Authors:  Sarah Differding; François-Xavier Hanin; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.